Drugs investment success must learn to take every step

Pharmaceutical investment promotion companies must not be quick-money, have a long-term commitment to long-term mentality, and must be based on the long-term basis to focus on the future now so that they can continue to develop. Sometimes we may be surprised by the big inspiration from small things. That's why we often ignore small things. From childhood, parents and teachers teach us to do anything from small things, especially mentality. We also heard people at work say that in the same unit, why people with strong working ability are not valued by the boss, on the contrary, those who are not able to work for him have received appreciation from the leaders. Sometimes the answer is the attitude. It is true that everything is decided, and such examples are not exhaustive. The same is true when it comes to pharmaceutical investment promotion. If people from all companies work together, perhaps this company will achieve its expected goal after a few years of struggle. We often see that some pharmaceutical investment enterprises are often quick and profitable in order to develop and grow as quickly as possible. The consequences are always the same. The reality is contrary to regret.

Today's brand means network, brand means value, brand means market, brand means value added, brand means the future, non-branded companies are in fact not competitive, and are bound to decline. The construction of pharmaceutical investment promotion brands should become the eternal pursuit of the operation of investment enterprises. The effective establishment of the investment promotion brand is conducive to the continuous and healthy development of the enterprise, the continuous introduction of new products for the enterprise, the continuous firmness of the enterprise market network, and the continuous improvement of the sales of the enterprise. Irreplaceable role.

The establishment of investment promotion brands by pharmaceutical investment promotion companies should focus on three aspects: 1. To issue timely brand promotion in the authoritative media of the industry and to report and publicize by these authoritative media. It is believed that with the reports of these sections, the investment brand is bound to establish itself. And to the investment enterprises to play a different effect 2, is focused on the pharmaceutical industry's Internet publicity, the current rapid development of the Internet, in the major pharmaceutical websites for publicity, which is currently creating channel brand image of the most efficient and efficient way. 3, focus on long-term and pragmatic investment operations, establish an effective agency brand reputation. Under the premise of non-standard operation of the overall market, the power of word-of-mouth publicity is huge, and the effect of word-of-mouth publicity cannot be measured.

If pharmaceutical investment enterprises want to develop for a long time, they must position themselves in the market products they are doing. They can't behave as if they are eyebrows and beards. As long as they are drugs, they are doing business. In fact, this blind practice is extremely wrong. This is often not the case. Focus on the positioning of its own product market is not clear, eventually leading to complex product varieties and lack of competitiveness. At present, the investment products selected by the various investment enterprises are nothing more than these categories: real new effective drugs, real new effective drugs, improved product formulations, replacement packaging, re-listed drugs and general drugs after the conversion of specifications, that is, those There is no need for any prominent drugs.

Starting from the basics is like doing a human job. It must start from the basics. The performance in the aspect of pharmaceutical investment is to do a good job at the grassroots level, that is, basic services. In general, it means delivery, materials and invoices. The most important thing is to provide The integrity of the data. A seemingly simple matter that allows different people to do it will have different results, so small things should also be taken seriously. The rapid development of the service industry proves this very well. If good drugs are matched with good services, we believe that more investment opportunities will be ushered in.

In addition, accurate positioning of customer goals is equally important for investment enterprises. The customers faced by pharmaceutical investment enterprises are mostly businessmen who work as drug agents, but they are also drug agents. The gap is very large. Each target customer has a relatively different market operation method. Each target customer has different regional characteristics. Each target customer is also faced with a very different situation in the downstream terminals. In this case, the market development of investment promotion operations must be effectively subdivided for the target customers. According to the differences in the characteristics of their products, the main sales channels of their products are different, and the characteristics of each different sales channel are accurately analyzed. And grasp, according to these characteristics to develop different targeted investment policies and methods of operation of the business, in the positioning of the target customers to follow the choice of appropriate customer operations, so that determine the target customers is very important.

If a pharmaceutical investment enterprise wants to truly engage in business investment for a long time, it must not only lay a solid foundation in the mentality, but also must do a good job of protecting the market from the actual aspects. Only in this way can a long-term healthy development be achieved, and there will be no market protection investment enterprise from the short term. Seeing indeed earn a lot of money, but with the development, it is the self that will ultimately hurt. Establishing a sense of belonging among individual agents through effective measures is a key aspect of maintaining and attracting individual agents' willingness to cooperate for a long time. The loyal partners of pharmaceutical investment enterprises have become our cooperation relationships that are not employees more than employees. This is undoubtedly an infringement of one agent. After all, agents with mature networks are limited.